Oxford Performance Materials (OPM) is a fascinating company founded in 2000 to exploit and commercialize the use of poly-ether-ketone-ketone (PEKK) through additive manufacturing for medical and industrial applications. The company developed a high-performance additive manufacturing (HPAM) process (a modified laser sintering approach) to produce fully functional, end-use structural parts. Now the company is furthering its expansion into key Asia markets: business development of OPM Asia, a partnership with Tokyo-based JSR Corporation (JSR), is now led by experienced medical device sector executive Curt Jennewine, who will serve as will serve as OPM Asia’s Executive Vice President of Sales and Marketing.
OPM Asia will establish a world-class biomedical manufacturing and market development operation in Japan for the Asian territory. Under the terms of the engagement, Mr. Jennewine will work to identify partnering opportunities with Asian medical technology manufacturers that will generate near-term profitable growth as well as establish OPM’s 3D printed OsteoFab implantable devices and OXPEKK biomedical materials as technologies of choice in Japan and throughout Asia.
Mr. Jennewine will begin by focusing on sales and marketing opportunities in Japan, China, Korea and Taiwan. “We’re very excited to have Curt Jennewine lead our commercial efforts in Asia,” said Scott DeFelice, Chief Executive Officer of Oxford Performance Materials and OPM Asia. “Curt has demonstrated an impressive 20-year track record of commercial success for leading medical technology companies, with over 12 of those years in Asia. Curt has strong existing relationships with OPM Asia target customers, and his fluency in Japanese will facilitate the quick and effective growth of our Japanese business. We established OPM Asia to enable a broad introduction of OPM’s technology in Asia, and Curt has the perfect set of skills to accomplish that goal.”
In the past, Mr. Jennewine has held executive and leadership positions at companies such as Zimmer, Abbott, Acumed and Guidant. Mr. Jennewine earned his undergraduate degree at Duke University and his MBA at Northwestern’s Kellogg School of Management. “The increasing conversion to OPM’s PEKK-based products in the United States provides early Asian adopters with an outstanding opportunity to differentiate their portfolios and win share from their competitors.” Mr. Jennewine commented. “Research has shown that OPM’s 3D printed OsteoFab implant surface technology provides strong osteoconductive as well as antibacterial characteristics. This technology offers significant, unique value to the patients, physicians and healthcare systems that adopt it.”
As previously announced in March, OPM was granted Accreditation of Foreign Medical Device Manufacturer status by the Japanese Ministry of Health, Labour and Welfare. OPM Asia is scheduled to establish its Japanese manufacturing facility in late 2018 with products commercially available to the Asian market in Q2, 2019.